HVPGHepatic Venous Pressure Gradient
Copyright 1988-2018 AcronymFinder.com, All rights reserved.
References in periodicals archive ?
Equity investments were provided by Belveron and HVPG along with a Fannie Mae mortgage through Prudential.
A significantly higher prevalence of GU was found in patients with LC who have hepatic venous pressure gradient (HVPG) >12 mmHg, amounting to 20.8% compared to 4% in healthy controls [10].
Regression of liver fibrosis and portal hypertension can be evaluated with liver biopsy and HVPG measurement, respectively [21, 22].
The WHVP indirectly estimates the portal pressure and if the difference between the two measurements, called the HVPG, is greater than 6 mmHg, this signifies sinusoidal portal hypertension.
Recently, it has been shown that the HVPG deposition is successful in synthesizing nanostructured Sn[O.sub.2].
Liver transient elastography demonstrated quite high sensitivity, specificity, and accuracy (0.88, 0.87, and 0.88, resp.) to predict clinically significant PHT [14], but not enough to replace the invasive HVPG measurement.
The established standard for diagnosing portal hypertension is transjugular measurement of the hepatic venous portal gradient (HVPG), the difference between wedged and free hepatic venous pressures.
The study of 100 patients with hepatitis C and compensated cirrhosis showed that the probability of developing a first episode of liver decompensation at 1, 5, and 7 years was 4%, 25%, and 28%, respectively, among patients with an hepatic venous pressure gradient (HVPG) value of 10 mm Hg or above, compared with 0, 0, and 16% in patients without cirrhosis with severe portal hypertension (CSPH).
Regarding using CPA for diagnosis and substaging of cirrhosis, a significant correlation between the values of CPA and LS or hepatic vein pressure gradient (HVPG) within the compensated phase was suggested by several recent studies; [sup][24],[42],[45] the underlying rationale for it might be, since cirrhosis is histologically defined as a pathological condition that tissue architecture is distorted by diffuse fibrous ECM (mainly consisting of FC I and III), the amount of FC might start to play a major role in predicting progression of cirrhosis before the stage of advanced portal hypertension (i.e., HVPG ≥ 12 mmHg); so that during the course of compensated cirrhosis, HVPG could be influenced significantly by FC quantity, which is what the values of CPA and LS mainly indicate.
When the HVPG rises above 10 mm of Hg, complications of portal hypertension can arise.